21.18
+0.65
+(3.17%)
At close: 4:00:00 PM EDT
21.18
0.00
(0.00%)
After hours: 4:05:13 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.27 | -0.19 | -0.54 | 0.28 |
| Low Estimate | -0.33 | -0.22 | -0.6 | 0.12 |
| High Estimate | -0.19 | -0.17 | -0.47 | 0.53 |
| Year Ago EPS | -0.86 | 0.84 | -1.65 | -0.54 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | 7.07M | 7.92M | 32.92M | 44.33M |
| Low Estimate | 4.06M | 5.56M | 21.5M | 25M |
| High Estimate | 8.2M | 9.2M | 38M | 52M |
| Year Ago Sales | 1.49M | 11.09M | 28.49M | 32.92M |
| Sales Growth (year/est) | 374.16% | -28.60% | 15.58% | 34.62% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.81 | -0.27 | -0.41 | -0.3 |
| EPS Actual | -0.86 | 0.84 | -1.59 | -0.06 |
| Difference | -0.05 | 1.11 | -1.18 | 0.24 |
| Surprise % | -6.17% | 415.00% | -283.13% | 80.22% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.27 | -0.19 | -0.54 | 0.28 |
| 7 Days Ago | -0.3 | -0.2 | -0.56 | 0.3 |
| 30 Days Ago | -0.28 | -0.2 | -0.6 | 0.47 |
| 60 Days Ago | -0.29 | -0.25 | -0.91 | 0.16 |
| 90 Days Ago | -0.29 | -0.25 | -0.55 | 0.16 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | 2 |
| Up Last 30 Days | 1 | 1 | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| XOMA | -- | -- | -- | -- |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
| Initiated | Benchmark: Buy | 4/17/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/19/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/3/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/13/2024 |
Related Tickers
EWTX Edgewise Therapeutics, Inc.
13.45
+3.22%
TECX Tectonic Therapeutic, Inc.
17.02
-3.08%
PRTC PureTech Health plc
16.74
+0.02%
IMVT Immunovant, Inc.
15.15
+2.09%
ENZN Enzon Pharmaceuticals, Inc.
0.0900
0.00%
LGND Ligand Pharmaceuticals Incorporated
104.97
+0.33%
NUVB Nuvation Bio Inc.
1.9700
+4.79%
KRRO Korro Bio, Inc.
13.90
+3.27%
RNXT RenovoRx, Inc.
1.0200
-0.97%
RPRX Royalty Pharma plc
32.60
+1.27%